RCB18350 - CAS 3052630-27-7

RCB18350 is an antituberculosis agent and an isoxazole derivative. It demonstrates bacteriostatic properties by inhibiting the growth of Mycobacterium tuberculosis, with a minimum inhibitory concentration (MIC) of 1.25 μg/mL. RCB18350 is effective against multi-drug resistant Mycobacterium tuberculosis (MDR-TB) clinical isolates, Mycobacterium bovis BCG, and Mycobacterium avium, all of which are slow-growing mycobacteria.

Antibacterial

Microbiology/Virology

3052596

C19H18F3N3O4S

441.424

O=C(OCC)C1=NOC(=C1)CCCSC=2C=CC(=CC2C)C3=NOC(=N3)C(F)(F)F

-20°C

Ice Packs

Small Compound